Literature DB >> 17981256

Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.

Peter Charbel Issa1, Hans-Martin Helb, Frank G Holz, Hendrik P N Scholl.   

Abstract

PURPOSE: To correlate macular thickness determined by optical coherence tomography (OCT) with light increment sensitivity and visual acuity in patients with type 2 idiopathic macular telangiectasia (IMT).
DESIGN: Prospective, cross-sectional study.
METHODS: Fifty-one eyes of 30 patients with type 2 IMT were investigated. Functional assessment included best-corrected visual acuity and fundus-related microperimetry (MP1; Nidek Technologies, Padova, Italy). Retinal thickness was analyzed quantitatively by OCT3 (Carl Zeiss Meditec, Jena, Germany). The main outcome measure was the correlation of light sensitivity and visual acuity with retinal thickness.
RESULTS: Mean central retinal thickness was reduced compared with that of normal eyes. There was no significant correlation between central foveal thickness and foveal light sensitivity or visual acuity, respectively. Also, there was no significant correlation between mean retinal thickness temporal to the fovea and the lowest light sensitivity within that area. However, central light sensitivity in eyes with normal central foveal thickness was lower than in eyes with subnormal central foveal thickness (P = .032); this was also true for the lowest light sensitivity found temporal to the fovea (P = .025). Mean visual acuity was 20/40 and did not show significant differences in the two thickness groups.
CONCLUSIONS: A subnormal foveal thickness in type 2 IMT may be associated with better macular function as assessed by microperimetry. It is hypothesized that in type 2 IMT, both a primary neurosensory thinning and a low-grade macular edema can be involved. The coincidence may result in normal retinal thickness but decreased retinal function.

Entities:  

Mesh:

Year:  2007        PMID: 17981256     DOI: 10.1016/j.ajo.2007.08.028

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry.

Authors:  Annal D Meleth; Pradeep Mettu; Elvira Agrón; Emily Y Chew; Srinivas R Sadda; Frederick L Ferris; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

2.  Treatment of nonneovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase II clinical trial.

Authors:  Brian C Toy; Euna Koo; Catherine Cukras; Catherine B Meyerle; Emily Y Chew; Wai T Wong
Journal:  Retina       Date:  2012-05       Impact factor: 4.256

3.  Macular cysts, holes and cavitations : 2006 Jules Gonin lecture of the Retina Research Foundation.

Authors:  A Gaudric
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-30       Impact factor: 3.117

4.  Perifoveal müller cell depletion in a case of macular telangiectasia type 2.

Authors:  Michael B Powner; Mark C Gillies; Marina Tretiach; Andrew Scott; Robyn H Guymer; Gregory S Hageman; Marcus Fruttiger
Journal:  Ophthalmology       Date:  2010-08-03       Impact factor: 12.079

5.  [Morphological characteristics in macular telangiectasia type 2].

Authors:  P Charbel Issa; T F C Heeren; E Krüger; M Zeimer; D Pauleikhoff; F G Holz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

6.  Demographic features of idiopathic macular telangiectasia in Japanese patients.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Akira Ojima; Hiroshi Oyamada; Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2012-01-06       Impact factor: 2.447

7.  Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema.

Authors:  Martin Roesel; Andreas Henschel; Carsten Heinz; Martha Dietzel; Georg Spital; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

8.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

9.  Metamorphopsia in patients with macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Frank G Holz; Hendrik P N Scholl
Journal:  Doc Ophthalmol       Date:  2009-08-27       Impact factor: 2.379

Review 10.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.